CY1112032T1 - Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας - Google Patents

Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας

Info

Publication number
CY1112032T1
CY1112032T1 CY20111101092T CY111101092T CY1112032T1 CY 1112032 T1 CY1112032 T1 CY 1112032T1 CY 20111101092 T CY20111101092 T CY 20111101092T CY 111101092 T CY111101092 T CY 111101092T CY 1112032 T1 CY1112032 T1 CY 1112032T1
Authority
CY
Cyprus
Prior art keywords
treatment
butoxyminomethylcomptothekine
mathematics
domestic
butoxyiminomethylcamptothecin
Prior art date
Application number
CY20111101092T
Other languages
English (en)
Inventor
Paolo Carminati
Marco Corsi
Claudio Zanna
Franco Cavalli
Luca Gianni
Cristiana Sessa
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1112032T1 publication Critical patent/CY1112032T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η χρήση της 7-t-βουτοξυιμινομεθυλοκαμπτοθεκίνης περιγράφεται στην παρασκευή ενός φαρμάκου χρήσιμου για τη θεραπεία νεοπλασμάτων της μήτρας, συγκεκριμένα του καρκίνου του ενδομητρίου και του τραχήλου της μήτρας.
CY20111101092T 2004-06-11 2011-11-14 Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας CY1112032T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000288A ITRM20040288A1 (it) 2004-06-11 2004-06-11 Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
EP05761294A EP1773451B1 (en) 2004-06-11 2005-06-08 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms

Publications (1)

Publication Number Publication Date
CY1112032T1 true CY1112032T1 (el) 2015-11-04

Family

ID=34979678

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101092T CY1112032T1 (el) 2004-06-11 2011-11-14 Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας

Country Status (23)

Country Link
US (1) US7700613B2 (el)
EP (1) EP1773451B1 (el)
JP (2) JP2008501785A (el)
KR (1) KR101221640B1 (el)
CN (2) CN1953784A (el)
AR (1) AR049220A1 (el)
AT (1) ATE521351T1 (el)
AU (1) AU2005251573B2 (el)
BR (1) BRPI0511931A (el)
CA (1) CA2565213C (el)
CY (1) CY1112032T1 (el)
DK (1) DK1773451T3 (el)
ES (1) ES2372056T3 (el)
HK (1) HK1205951A1 (el)
HR (1) HRP20110718T1 (el)
IT (1) ITRM20040288A1 (el)
MX (1) MXPA06014162A (el)
PL (1) PL1773451T3 (el)
PT (1) PT1773451E (el)
RS (1) RS52038B (el)
SI (1) SI1773451T1 (el)
TW (1) TWI351283B (el)
WO (1) WO2005120643A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915134A2 (en) * 2005-08-10 2008-04-30 Novartis AG Formulations for 7-(t-butoxy)iminomethyl camptothecin
CA2676986A1 (en) * 2007-02-01 2008-08-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pharmaceutical composition comprising a campothecin derivative

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1251125T3 (da) * 1995-06-21 2006-04-18 Sod Conseils Rech Applic Hidtil ukendte camptothecin-analoger, fremgangsmåde til fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
UA57757C2 (uk) * 1996-12-20 2003-07-15 Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція
ES2175919T3 (es) * 1999-03-09 2002-11-16 Sigma Tau Ind Farmaceuti Derivados del camptothecin con actividad antitumoral.
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
WO2003043584A2 (en) 2001-11-20 2003-05-30 University Of Kentucky Research Foundation Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins
BRPI0410648A (pt) * 2003-05-21 2006-07-04 Novartis Ag combinação de inibidores de histona desacetilase com agentes quimioterápicos

Also Published As

Publication number Publication date
CN104352496A (zh) 2015-02-18
EP1773451A2 (en) 2007-04-18
JP2008501785A (ja) 2008-01-24
KR101221640B1 (ko) 2013-01-14
AU2005251573B2 (en) 2010-04-15
US7700613B2 (en) 2010-04-20
AR049220A1 (es) 2006-07-05
ITRM20040288A1 (it) 2004-09-11
TWI351283B (en) 2011-11-01
WO2005120643A3 (en) 2006-03-30
EP1773451B1 (en) 2011-08-24
WO2005120643A8 (en) 2006-12-14
CN1953784A (zh) 2007-04-25
PL1773451T3 (pl) 2012-01-31
PT1773451E (pt) 2011-11-02
BRPI0511931A (pt) 2008-01-22
JP2014231518A (ja) 2014-12-11
DK1773451T3 (da) 2011-11-28
ATE521351T1 (de) 2011-09-15
ES2372056T3 (es) 2012-01-13
RS52038B (en) 2012-04-30
US20080020030A1 (en) 2008-01-24
SI1773451T1 (sl) 2012-01-31
AU2005251573A1 (en) 2005-12-22
CA2565213C (en) 2012-08-07
MXPA06014162A (es) 2007-03-07
KR20070030246A (ko) 2007-03-15
HK1205951A1 (en) 2015-12-31
CA2565213A1 (en) 2005-12-22
HRP20110718T1 (hr) 2011-12-31
TW200605891A (en) 2006-02-16
WO2005120643A2 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
CY1110254T1 (el) Φαινυλακεταμιδια και χρησις των ως διαμορφωται γλυκοκινασης
ES2433841T8 (es) Dispositivo para tratar prolapsos de órganos pélvicos en pacientes de sexo femenino
CY1104983T1 (el) Αντινεοπλασματικοι συνδυασμοι
ATE447396T1 (de) Pharmazeutisches vaginales gel mit tenofovir
NO20020554L (no) Antistoff-molekyler med spesifisitet for human tumornekrosefaktor-alfa, og anvendelse derav
CY1108109T1 (el) Χρηση cci-779 ως αντινεοπλασματικου παραγοντα
ITFI20020145A1 (it) Dispositivo per il trattamento chirurgico del prolasso femminile.
CY1116052T1 (el) Θεραπευτικα και διαγνωστικα αντι-ηsρ70 αντισωματα
CY1107605T1 (el) Θεραπευτικη αγωγη
BR8102729Y1 (pt) dispositivo portÁtil para higienizaÇço dental.
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
DK1513836T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
ATE399532T1 (de) Medizinische seife
CY1112032T1 (el) Χρηση της 7-τ-βουτοξυιμινομεθυλοκαμπτοθεκινης για τη θεραπεια νεοπλασματων της μητρας
SI1869185T1 (sl) Konjugat ki obsega protein P za zdravljenje raka
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
IT1318509B1 (it) Polimeri reticolati, utili per uso farmaceutico, medicale e cosmetico.
CY1112144T1 (el) Ενωση χρησιμη για την προληψη και θεραπεια της υπερτροφιας αριστερης κοιλιας σε ασθενεις υπο αιμοκαθαρση
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini